bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?
bioAffinity Technologies jumped 47.95% on September 2, one day after announcing that it was advancing the potential use of CyPath Lung for post-treatment surveillance of lung-cancer patients. The move followed a 1-for-15 reverse split that…
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
bioAffinity Technologies, Inc.'s BIAF investors have been experiencing some short-term losses. Shares of the San Antonio, TX-based biotechnology company have lost 77% in the past three months against the industry's 4.5% rise. It has also u…
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans
Expert panel will share real-world case studies to demonstrate how mobile CT screening, noninvasive CyPath® Lung testing, and comprehensive functional lung imaging can reduce cost while improving access, early detection and outcomes for ve…
BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung
Shares of bioAffinity Technologies, Inc. BIAF have lost 10.9% since the company reported earnings for the quarter ended March 31, 2026, against the S&P 500 Index’s 1.4% gain over the same time frame. Over the past month, the stock plunged…
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?
bioAffinity Technologies, Inc. BIAF investors have been experiencing some short-term gains lately, despite the stock’s bumpy ride in recent months. Shares of the diagnostics company specializing in the development of non-invasive tests to…
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change iSpecimen Inc. 186,331,747 0.4359 0.3637 0.367 +0.143 bioAffinity Technolo…
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this landscape, bioAffinity Technologies, Inc. BIAF a…
bioAffinity Technologies launches $1.8M direct financing
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) has entered into definitive agreements for the purchase and sale of 720,000 shares of common stock, par value $0.007 per share, at a purchase price of $2.50 pe…
bioAffinity Technologies prices $4.8 million public offering; shares down over 30%
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) announced on Monday that it has priced a public offering of securities for aggregate gross proceeds of $4.8 million, before deducting agent fees and other esti…
bioAffinity Technologies announces 1-for-30 reverse stock split to regain Nasdaq compliance; shares down ~22%
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) will implement a 1-for-30 reverse stock split effective at market open on September 19, 2025. * The reverse split reduces the outstanding common shares to ~1.3…
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT GORV [https://www.chartmill.com/stock/quote/GORV/profile] 147.0% With a 147.0% surge,…
Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT FGI [https://www.chartmill.com/stock/quote/FGI/profile] 138.0% In an impressive…
Let's uncover which stocks are experiencing notable gaps during today's session.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT…
Monday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66% After the regular…
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. [topmovers] GAINERS TICKER CHANGE COMMENT ATCH [https://www.chartmill.com/stock/quote/ATCH/profile] 148.0% ATLASCLEAR HOLDINGS INC'S (NYSEAR…
Curious about the most active stocks on Monday? Find out which stocks are dominating the market action! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT ATCH [https://www.chartmill.com/stock/quote/ATCH/profile] 147.0% So far,…
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT ATCH [https://www.chartmil…
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. [gap] TOP GAP UP STOCKS TICKER CHANGE COMMENT NAOV [https://www.char…
Monday's pre-market session: top gainers and losers
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT GPUS [https://www.chartmill.com/stock/q…
These stocks are moving in today's after hours session
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] GAINERS TICKER CHANGE COMMENT CHEK [https://www.chartmill.com/stock/quote/CHEK/pro…
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied…
BioAffinity Technologies files to sell 12.61M shares of common stock for holders
* BioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) files to sell 12.61M shares of common stock for holders. * Filing [https://seekingalpha.com/filing/10365120] MORE ON BIOAFFINITY TECHNOLOGIES * bioAffinity Tec…
bioAffinity Technologies earnings missed by $0.07, revenue topped estimates
Investing.com - bioAffinity Technologies (NASDAQ: BIAF) reported second quarter EPS of $-0.170, $0.07 worse than the analyst estimate of $-0.100. Revenue for the quarter came in at $1.27M versus the consensus estimate of $1.21M. bioAffinit…
The Zacks Analyst Blog Highlights Meta Platforms, ServiceNow, Booking, Vaso and bioAffinity Technologies
For Immediate Release Chicago, IL – July 1, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial mark…
VOR Skyrockets On Ex-China Rights To Autoimmune Drug, ADIL To Face FDA On Jul.29, PSTV Jumps 14%
(RTTNews) - What's driving the momentum in the following stocks? Vor Bio, Inc. (VOR) has secured ex-Greater China rights from RemeGen Co., Ltd. to develop and commercialize Telitacicept, a novel dual-target fusion protein approved in China…
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on cancer diagnostics and targeted therapeutics, will present findings today related to the discovery of a potential broad-s…
bioAffinity Technologies receives Chinese patent for cancer therapy
SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF), currently trading at $0.23 and down nearly 88% over the past year, has been granted a patent by the China National Intellectual Property Administration for its composition and met…
BioAffinity Technologies announces pricing of $3.25M offering
WallachBeth Capital announced that bioAffinity Technologies (BIAF) priced a best efforts offering of securities for aggregate gross proceeds to the company of $3.25M, before deducting agent fees and other estimated expenses payable by the…
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
Penny sleeper stocks can offer tremendous risks to investors. However, much like any other speculative investment category, it’s possible that traders can still generate incredible, perhaps life changing profits. Let’s start with the pros…